Lecture inherited platelet function disorders

Page 1

INHERITED PLATELETS DISORDERS Akram Al-Hilali 2009

08/06/14

1


PLATELET STRUCTURE outer membrane actin microtubules surface connected canalicular system dense (δ) granules alpha(ι) granules glycogen mitochondria

08/06/14

2


PLATELET PHYSIOLOGY-1 Inactive Platelet

Activated Platelet

AGGREGATION AND SECRETION 08/06/14

3


PLATELET PHYSIOLOGY-2 Receptors & Ligands    

 

08/06/14

GPIa GPIb GPIIa GPIIb+IIIa

GPV GPIX

  

Collagen vW Factor Collagen Fibrinogen & vW Factor Thrombin vW Factor

4


RECEPTORS & LIGANDS aling n g i S s way h t a p

Signal transduction

NUCLEUS ct fe f e

R

DNA Cell Cytoplasm

Cell membrane

08/06/14

5

Ligand


PLATELET METABOLISM Collagen

Collagen phospholipase

PHOSPHOLIPIDS

ARACHIDONIC ACID Cyclo-oxygenase

Pl F4

ENDOPEROXIDES

dense body

ADP Release Reaction

ADP

thromboxane synthetase

TXA2

ENDOPEROXIDASES

Thromboglobulin

Aggregation

08/06/14

ARACHIDONIC ACID

ADP & THROMBOXANE

6


PLATELET PHYSIOLOGY-3 Platelet Collagen vWF

vWF

GPIb IX

GPIIb IIIa

Platelet Tissue adhesion

08/06/14

GPII b IIIa

Fibrinogen GPIIb IIIa Platelet

Aggregation 7


PLATELET PHYSIOLOGY-4 Intact Blood Vessel erythrocyte platelets lumen leukocyte (PMN) endothelial cell basal membrane collagen fibers smooth muscle cells 08/06/14

8


Injured blood vessel endothelium erythrocyte lumen endothelial cell basal membrane non-activated platelets activated platelets collagen fibers smooth muscle cells 08/06/14

9


Platelet aggregation lumen endothelial cell basal membrane erythrocytes activated platelets plug stabilisation by fibrin formation

08/06/14

10


PLATELET DYSFUNCTION Provisional Investigation

Document sites, duration and amount of bleeding especially epistaxis, menorrhagia and mucosal bleeding, History of systemic illness, medications, family history. Examine and document bleeding and signs of systemic disease

CBC and smear, PTT, PT, TT Normal platelet count and morphology

New onset bleeding

Other investigation Diagnosis Management

Normal to slightly Low platelet count And large size

Recurrent infection, Eczema, lymphoreticular Malignancies, males

Specific morphologic abnormality

Lifelong bleeding PTT FVIII,vWF Ag,vWF:RCo

Platelet inhibiting drugs Yes

Normal to slightly low Platelet count and small Platelet size

Normal

No

Repeat Liver & Renal tests Abnormal

Manage

Stop drug Underlying If 08/06/14 possible disease

No

Yes

No

Yes

Von Willebrand’s disease

Normal Normal Abnormal CBC and Blood smear

Uremia Drug-induced Liver disease Underlying Platelet dysfunction

Abnormal

Platelet aggregation studies

Normal Abnormal Abnormal

Intrinsic platelet MDS Dysfunction Glanzmann BMA BMB

vW multimer assay

X-linked thrombocytopenia Amegakaryocytosis

WiskottAldrich

Brenard-Soulier: Very large platelets Abnormal ristocetin aggregation May-Hegglin: Large platelets+Dohle bodies Gray platelet syndrom: Large, pale platelets

Type I vWD Type 2A,2B, 3, DDAVP Splenectomy may Platelet type---vWF replacement. reduce bleeding Rarely platelet DDAVP Challenge Platelet transfusion for latter transfusion BMT

11

ITP,Oth macroth bocytope

Platelet dysfunc Can be seen in I But low count i important


INVESTIGATION PLAN History & PE CBC & Diff Peripheral smear

Hgb & WBC

Abnormal

Normal

CONSULT HAEMATOLOGIST

Platelet Morphology

Abnormal

Normal Splenomegaly & Lymphadenopathy

CONSULT HAEMATOLOGIST

Absent

Present

Check for congenital anomalies Present

CONSULT HAEMATOLOGIST (Malignancy,HIV, infection, hypersplenism)

Absent H/O drugs, HIV Collagen disease

CONSULT HAEMATOLOGIST Fanconi,TAR,WiScott Aldrich

Positive

Negative Count <70K

Possible ITP

Count 70 K or more

SPECIALTY CONSULTATION

Treat

•if count is < 20K •Count is >20 K with serious mucocutaneous bleeds • there is serious or lifethreatening bleed.

FOLLOW CLINICALLY

Evaluation of Patient with Petichiae

08/06/14

12


08/06/14

Dr. Akram Al-Hilali-2002 13


Main Classes of Platelet Dysfunction 

Defective adhesion  Platelet

defect  Collagen defect  vW factor defect 

Defective release  Sorage

pool defect  Cyclo-oxygenase deficiency  Nucleotide metabolism defect 

Defective ADP aggregation  Glanzmann’s

disease  Afibrinogenemia 08/06/14

14


Main Types of Platelet Dysfunction INHERITED:  GPIIb/IIIa Deficiency: Glanzmann's Disease inherited  GPV, GPIa, GPV or GPIX deficiency-Bernard Soulier Disease. e  PLF4 and Thromboglobulin Deficiency- Defective activation of platelets with effect on clotting and clot retraction.  Grey platelet syndrome.  ADP and Epinephrine Deficiency- Storage Pool Disorder  vW Factor Deficiency- vWD I  Others ACQUIRED • Aspirin-induced: Inhibition of cyclo-oxygenase • Acquired vWD: Antibodies to vWF causing inactivation, destruction or prevention of release. In malignancy and autoimmune diseases. Rare 08/06/14

15


CLINICALLY IMPORTANT INHERITED DISORDERS-1 Glanzmann’s Thromboasthenia       

GPIIb/IIa deficiency-Cannot stick to fibrinogen (Defective aggregation) Autosomal recessive Severe disease. Normal Platelet count and size Abnormal aggregation screen. No native aggregation No aggregation with ADP, Thrombin, Collagen and Epinephrine

08/06/14

16


CLINICALLY IMPORTANT INHERITED DISORDERS-2 Bernard-Soulier Disease

Platelet adhesion anomaly.  Deficiency of GP1b or IX and V.  Giant platelets with moderate thrombocytopenia, partly due to platelet size.  Bleeding. 

08/06/14

17


CLINICALLY IMPORTANT INHERITED DISORDERS-3 Storage Pool Disorder

Absence or Deficiency of dense granules.  Lack or deficiency of epinephrine and ADP  Decreased aggregation with collagen  Gives clinical bleeding.  Could be simple platelet defect or part od other disease (W-A,H-P, Ch-H) 

08/06/14

18


CLINICALLY IMPORTANT INHERITED DISORDERS-4 Von Willebrand’s Disease  

   

Not basically a platelet disease Deficiency of the vWF leads to diminished adhesion activity of platelets because vWF is the intermediary between collagen and platelets. Aggregation with ristocetin- defective 2 nd phase Many Types and variable severity. Type III is most severe. Type I is commonest FVIII activity in plasma is diminished in I and III

08/06/14

19


RARE INHERITED DISORDERS          

May Hegglin: Giant, pale platelets. Neutrophil inclusions like Döhle bodies. Cyclo-oxygenase deficiency: (Aspirin-like, defective release) Wiscott-Aldrich: Tiny platelets. Immune deficiency (Platelet defect is storage pool).X-linked Hermansky-Pudlak: abnormal aggregation (storage pool defect). Albinism. Montreal Syndrome: like B-S dominant. Adhesion defect. Defective Nucleotide metabolism: in some glycogen storage diseases causing low ADP and ATP. Defective release. Epstein Syndrome: Thrombocytopenia, giant platelets, nephritis, deafness. Gray platelet syndrome: Alpha granules deficiency- storage pool. Alpha-Delta granules deficiency: storage pool. Many factors missing as a result. Afibrinogenemia

08/06/14

20


Non-platelet abnormalities leading to platelet function defects - Ehler Danlos Disease:

there is structural collagen abnormality that prevents normal platelet adhesion to it.

-

vW Disease: Deficiency of intermediary factor between platelets and collagen.

-

Afibrinogenemia: Deficiency of intermediary factor between one platelet and another.

08/06/14

21


ASPIRIN EFFECT Collagen

A S P I R I N

Collagen phospholipase

PHOSPHOLIPIDS

ARACHIDONIC ACID

Cyclo-oxygenase ENDOPEROXIDES

dense body

No ADP Release

thromboxane synthetase

TXA2

ARACHIDONIC ACID

X ENDOPEROXIDASES

ADP 08/06/14

No Aggregation

TXA2

ADP & THROMBOXANE 22


DIAGNOSIS OF THE ANOMALIES History  Platelet count  Platelet size by MPV and Blood film  Lab tests available are many. Most widely used is bleeding time, which is not an accurate or reproducible test 

08/06/14

23


LABORATORY TESTS     

Bleeding time PF-100: aggregation in whole blood specimen with epinephrine and collagen Platelet aggregometry: Time consuming. Needs expensive machine. Many agonists Flow cytometry: Antibodies against various surface molecules to detect deficiency Urinary Thromboxane: To assess platelet activation.

08/06/14

24


OTHER LABORATORY TESTS “Verify now” test: Plastic beads coated with fibrinogen for platelet aggregation on surface: Light path method.  Thrombo-elastography  Global Thrombosis Test (GTT): Native blood. No agonists used. 

08/06/14

25


CONCLUSIONS 

 

Inherited platelet function disorders is an interesting group of diseases that have to be in mind when dealing with bleeding. Systematic thinking and planning are needed in order to reach the right conclusion. Acquired conditions due to antiplatelet drugs are certainly more common: ASA, Anagrelide, Dipyridamole. They are causing a lot of management problems when patient goes for emergency surgery

08/06/14

26


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.